HeartMate II pump data grows for Thoratec following EU market approval
This article was originally published in Clinica
Executive Summary
Swiftly after gaining European market approval for its latest-generation heart-pumping device, Thoratec has released encouraging results from a phase I US trial of the product in patients with advanced heart failure.